DS Laboratories (the flagship brand of DS Healthcare) makes the well known Revita and Spectal DNC line of hair loss products for men and women.
Revita Shampoo from DS Laboratories
The most famous product from DS Labs is the Revita brand shampoo for hair growth stimulation. It contains several natural dihydrotestosterone (DHT) blockers as well as ketoconazole, caffeine, biotin, niacinamide, amino acids and more. Make sure to also read my related posts on natural DHT blockers and Revivogen shampoo.
According to DS Laboratories, Revita combines antioxidant and anti-androgenic properties. It also contains powerful hydrating molecules, hair-growth stimulants, and amino acids. It currently has 4,550 Amazon reviews with an average customer rating of 4.3 out of 5 stars. The company also sells Revita tablets and a higher strength Revita shampoo with saw palmetto.
Spectral DNC with Nanoxidil from DS Labs
DS Labs also makes the well known Spectral.DNC-N topical spray hair loss treatment. It contains the company’s proprietary Nanoxidil® 5% alternative to Minoxidil (Rogaine). The product makes use of nanosome delivery technology. I have not read about any users claiming major side effects. However, please do your own research from reading the almost 2,000 current customer reviews (averagin a 4.2 out of 5 star rating).
According to the official product description:
“The compounds used in Spectral.DNC-N have in clinical studies shown to open ion channels within cells; suppress dihydrotestosterone; prevent perifollicular fibrosis; provide antioxidant effects; prolong the anagen phase of hair follicles; increase expression of VEGF; suppress protein-kinase-C isozymes; and block chronic inflammation”.
Other well known products sold by DS Laboratories include: the Spectral.CSF hair revitalizing treatment for women; and the Dandrene brand anti-dandruff shampoo.
Nanoxidil
Nanoxidil is a molecule that resembles Minoxidil, but supposedly causes fewer adverse reactions. It comes in a liposome formulation that contains a potassium channel opener, pyrrolidinyl diaminopyrimidine oxide, azelaic acid, lysophosphatidic acid and copper tripeptide-1. A 2008 study from South Korea found 5% Nanoxidil to benefit hair growth in mice via increased IGF-1 expression and decreased TGF-beta1 expression.
A 2018 study found that topical Spectral DNC-N (which contains Nanoxidil 5%) reduced hair shedding in women with female pattern hair loss. It also increased hair mass and density. One of the authors of this study is the well known hair loss research scientist Dr. Antonella Tosti, who is also an advisor to DS Labs.
DS Healthcare Patents
DS Healthcare Group filed its second patent in 2019 (first one was filed in 2013) in relation to its proprietary topical hair loss treatment. From the news release regarding this development:
“This new patent addresses the composition and methods of a new compound described as a calcium-activated potassium channel opening agent for topical treatment of hair loss.”
According to the company’s CEO Daniel Khesin, this patent-pending molecule will produce better hair regrowth than topical minoxidil. Note that Mr. Khesin was the original CEO of DS Labs, prior to being replaced by Dr. Fernando Tamez in 2019 after a $2 million controversy ridden company buyout. It seems like Mr. Khesin took back the reigns as CEO in 2025.
Also of note, pharmaceutical company Megalabs acquired a majority stake in DS Laboratories in 2024 at an estimated cost of $100 million.